Duplex Scanning
J9 · Effective Oct 1, 2015
38 active Medicare policies list R53.83, and 15 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
JJ · Effective Feb 7, 2021
JM · Effective Feb 7, 2021
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J6 · Effective Aug 1, 2022
JK · Effective Aug 1, 2022
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
15 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of R53.83 |
|---|---|---|
| Acupuncture and Dry Needling | Apr 5, 2023 | Covered |
| Electrical Stimulation for Nausea, Vomiting, Motion Sickness and Other Selected Indications | Jan 5, 2024 | Covered |
| Enhanced External Counterpulsation (EECP) | Jun 7, 2023 | Covered |
| Intravascular Ultrasound | Nov 7, 2023 | Covered |
| Lead Testing | Aug 9, 2023 | Covered |
| Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT) | May 2, 2023 | Covered |
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JE · Effective Mar 13, 2017
JF · Effective Mar 13, 2017
J9 · Effective Oct 1, 2025
National · Effective Oct 1, 2023
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Oct 1, 2025
National · Effective May 7, 2026
J5 · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Jan 1, 2026
J9 · Effective Dec 18, 2025
National · Effective Oct 1, 2026
| Myalgic Encephalomyelitis - Chronic Fatigue Syndrome (ME/CSF) | Jun 21, 2023 | Covered |
|---|
| Polymerase Chain Reaction Testing: Selected Indications | Feb 9, 2024 | Covered |
|---|
| Policy | Effective | Status of R53.83 |
|---|---|---|
| Outpatient Urine Culture | Jan 6, 2026 | Covered |
| Per- and Polyfluoroalkyl Substances (PFAS) Testing | Oct 1, 2026 | Not covered |
| Selected Blood, Serum and Cellular Allergy and Toxicity Tests | Jul 1, 2026 | Not covered |
| Thyroid Testing | Apr 15, 2026 | Covered |
| Policy | Effective | Status of R53.83 |
|---|---|---|
| Concert Genetic Testing: Nutrition and Metabolism | Not recorded | Referenced |
| Holter Monitors | Not recorded | Covered |
| Policy | Effective | Status of R53.83 |
|---|---|---|
| Transvaginal Ultrasound, Non-Obstetrical | Mar 15, 2026 | Not covered |